Advertisement

Loading...

Cassiopea S.p.A.

SKIN.SW•SIX
Healthcare
Biotechnology
CHF35.70
CHF3.20(9.85%)
Swiss Market opens in 0h 29m

Cassiopea S.p.A. (SKIN.SW) Stock Overview

Explore Cassiopea S.p.A.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap0
P/E Ratio-32.77
EPS (TTM)$-1.27
ROE-1.27%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

SKIN.SW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cassiopea S.p.A. (SKIN.SW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -32.77 and a market capitalization of 0. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
N/A
3-Year Change
N/A
5-Year Change
N/A
All-Time (Max) Change
N/A

Contact Information

https://www.cassiopea.com
390286891124
Via Cristoforo Colombo 1, Lainate, NaN, 20020

Company Facts

110 Employees
IPO DateJul 1, 2015
CountryIT

Frequently Asked Questions